Nuvation Bio NUVB
NYSE NUVB
$5.13 -0.42 (-7.57%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nuvation Bio (NUVB) Gains from Sales and Divestitures (2022 - 2025)

Updated

Nuvation Bio (NUVB) posted Gains from Sales and Divestitures of -$33,000 for FY2025.

Analysis

Nuvation Bio (NUVB) Gains from Sales and Divestitures (2022 - 2025) Analysis & Trends

  • The FY2025 figure stands as the lowest annual Gains from Sales and Divestitures since FY2022.
  • Business Quant data shows NUVB's Gains from Sales and Divestitures at -$10,000 in FY2023 and -$50,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Nuvation Bio 1.78 Bn 1.78 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -34,000.00
Dec 31, 2024 171,000.00
Sep 30, 2024 -171,000.00
Dec 31, 2023 9,000.00
Sep 30, 2023 -7,000.00
Mar 31, 2023 -12,000.00
Dec 31, 2022 -18,000.00
Sep 30, 2022 -32,000.00
API Access

Nuvation Bio Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NUVB&period=max&api_key=YOUR_API_KEY